The role of surveillance imaging for resected high‐risk melanoma-Reference-Cited by-同舟云学术

The role of surveillance imaging for resected high‐risk melanoma

Published:2022-12-20 Issue: Volume: Page:
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia-Pac J Clncl Oncology

Author:

Yan Mabel K.¹²^ORCID,Adler Nikki R.²,Wolfe Rory²,Pan Yan¹³,Chamberlain Alexander¹³,Kelly John¹,Yap Kenneth³⁴,Voskoboynik Mark³⁵,Haydon Andrew³⁵,Shackleton Mark³⁵,Mar Victoria J.¹²

Affiliation:

1. Victorian Melanoma Service Alfred Health Melbourne Australia

2. School of Public Health and Preventive Medicine Monash University Melbourne Australia

3. Central Clinical School Monash University Melbourne Australia

4. Department of Nuclear Medicine and PET Alfred Health Melbourne Australia

5. Department of Medical Oncology Alfred Health Melbourne Australia

Publisher

Wiley

Subject

Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajco.13913

Reference25 articles.

1. Patterns and timing of initial relapse in pathologic stage II melanoma patients;Lee AY;Ann Surg Oncol,2017

2. Risk of melanoma recurrence after diagnosis of a high‐risk primary tumor;Schuckmann LA;JAMA Dermatol,2019

3. Systemic treatments for metastatic cutaneous melanoma;Crosby T;Cochrane Database Syst Rev,2018

4. Overall survival with combined nivolumab and ipilimumab in advanced melanoma;Wolchok JD;N Engl J Med,2017

5. Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open‐label phase 3 study (KEYNOTE‐006);Schachter J;Lancet,2017

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and Imaging Follow-Up for High-Risk Cutaneous Melanoma: Current Evidence and Guidelines;Cancers;2024-07-18